Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

BioSpecifics Technologies Corp. (BSTC)

57.55 1.87 (3.36%)

11-13 16:00

Open:

55.72

Pre. Close:

55.68

High:

59.3

Low:

55.72

Volume:

28,542

Market Cap:

419M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

59.355 - 59.643

59.643 - 59.891

Low:

55.059 - 55.378

55.378 - 55.653

Close:

57.063 - 57.567

57.567 - 58.003

Technical analysis  (as of: 2018-11-13 4:23:31 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 71.45     One year: 77.44

Support:

Support1: 52.88    Support2: 44.00

Resistance:

Resistance1: 61.17    Resistance2: 66.30

Pivot:

60.77

Moving Averages:

MA(5): 58.44     MA(20): 61.31

MA(100): 53.67     MA(250): 47.08

MACD:

MACD(12,26): -0.34     Signal(12,26,9): 0.48

%K %D:

%K(14,3): 24.36     %D(3): 23.46

RSI:

RSI(14): 43.11

52-Week:

High: 66.3  Low: 38.05  Change(%): 32.7

Average Vol(K):

3-Month: 3767  10-Days 3555

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
BSTC has closed above bottom band by 16.0%. Bollinger Bands are 40.7% wider than normal. The large width of the bands suggest high volatility as compared to BSTC's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.

Headline News

2018-11-09T08:08:22-05:00
BioSpecifics Tech beats by $0.14, beats on revenue

2018-11-09T08:01:00-05:00
BioSpecifics Technologies Corp. Reports Third Quarter 2018 Financial Results

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

7.29

Shares Float (M)

5.92

% Held by Insiders

19.10

% Held by Institutions

88.20

Shares Short (K)

Shares Short Prior Month (K)

Stock Financials

EPS

2.010

EPS Est. Current Year

1.590

EPS Est. Next Year

1.690

EPS Est. Next Quarter

0.420

Forward EPS

1.#IO

Book Value (p.s.)

4.820

PEG Ratio

1.15

Profit Margin

52.30

Operating Margin

67.54

Return on Assets (ttm)

17.1

Return on Equity (ttm)

18.3

Qtrly Rev. Growth

8.6

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

0.621

Qtrly Earnings Growth

63.90

Operating Cash Flow (M)

14.94

Levered Free Cash Flow (M)

6.54

Valuation

P/E

28.63

P/E Growth Ratio

0.03

P/BV

11.94

P/S

110115352.00

P/CF

28.10

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.